Cronos Group Inc. (CRON) stock analysis
CRON · Cronos Group Inc.
Latest recorded price: USD 3.27
Sector and industry: Healthcare · Drug Manufacturers - Specialty & Generic
Fiscal 2025 figures: revenue growth 16.8%, free cash flow margin 0.1%, ROIC -3.9%. The model flags 1 risk signal for this company.
Similar companies in Healthcare
- Elanco Animal Health Incorporated (ELAN)
- Eton Pharmaceuticals, Inc. (ETON)
- Hims & Hers Health, Inc. (HIMS)
- Harrow, Inc. (HROW)
- Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares (KNSA)
- Lantheus Holdings, Inc. (LNTH)
- Liquidia Corporation (LQDA)
- Neurocrine Biosciences, Inc. - Common Stock (NBIX)